Capital expenditure · 2013–2025
Novocure capital expenditure
$26.6M−37.8% · FY2025
Novocure (NVCR) reported $26.6M in capital expenditure for fiscal 2025, −37.8% year on year.
| Fiscal year | Capital expenditure | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $26.6M | −37.8% | Open → |
| FY20242024-12-31 | $42.9M | +58.2% | Open → |
| FY20232023-12-31 | $27.1M | +26.9% | Open → |
| FY20222022-12-31 | $21.4M | −11.6% | Open → |
| FY20212021-12-31 | $24.2M | +61.5% | Open → |
| FY20202020-12-31 | $15.0M | +42.8% | Open → |
| FY20192019-12-31 | $10.5M | +56.2% | Open → |
| FY20182018-12-31 | $6.7M | −8.9% | Open → |
| FY20172017-12-31 | $7.4M | +29.8% | Open → |
| FY20162016-12-31 | $5.7M | +21.6% | Open → |
| FY20152015-12-31 | $4.7M | +449.7% | Open → |
| FY20142014-12-31 | $849,000 | −61.4% | Open → |
| FY20132013-12-31 | $2.2M | — | Open → |
Capital expenditure — Capital expenditure is the cash the company spent during the year on property, plant and equipment — factories, stores, servers, vehicles. It appears in the investing section of the cash-flow statement as an outflow and is shown here as a positive amount. Operating cash flow minus this figure is free cash flow.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2013–2025 compound annual growth +23.1%
Capital expenditure at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Novocure capital expenditure |url=https://companiesranked.com/en/company/novocure/capital-expenditure |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Novocure capital expenditure. CompaniesRanked. https://companiesranked.com/en/company/novocure/capital-expenditureBibTeX
@misc{companiesranked-en-company-novocure-capital-expenditure-2026,
author = {{CompaniesRanked}},
title = {{Novocure capital expenditure}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/novocure/capital-expenditure}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001645113-26-000062 · July 23, 2026
{{cite web |title=Novocure capital expenditure — 10-Q (0001645113-26-000062) |url=https://www.sec.gov/Archives/edgar/data/1645113/000164511326000062/nvcr-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-07-23}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.